Emcure Pharmaceuticals Limited
Indian Pharmaceutical Exporter ยท Antiviral & HIV Medications Specialist ยท $147.8M Total Trade ยท DGFT Verified
Emcure Pharmaceuticals Limited is an Indian pharmaceutical exporter with a total trade value of $147.8M across 39 products in 19 therapeutic categories. Based on 5,154 verified export shipments from Indian Customs (DGFT) records, Emcure Pharmaceuticals Limited is the #1 Indian exporter in 3 products including Melphalan, Carmustine, Diltiazem. Top exports include Dolutegravir ($19.9M), Mycophenolate ($14.4M), Tenofovir ($14.3M).
Emcure Pharmaceuticals Limited โ Export Portfolio & Destination Treemap

Who is Emcure Pharmaceuticals Limited? โ Company Overview & Market Position
Emcure Pharmaceuticals Limited, established in 1981, is a leading Indian pharmaceutical company headquartered in Pune, Maharashtra. The company specializes in developing, manufacturing, and marketing a diverse range of pharmaceutical products across various therapeutic areas, including gynecology, cardiology, oncology, blood-related disorders, HIV antivirals, and more.
As of March 2026, Emcure reported a revenue of $943.7 million, reflecting an 18.6% increase from the previous year. The company employs approximately 11,474 individuals, underscoring its significant presence in the pharmaceutical industry. Emcure's product portfolio includes over 350 brands, with notable offerings such as Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym.